Thu.Jul 30, 2020

article thumbnail

Made-in-Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials

Pharma Mirror

First dose of ETC-159 administered in Phase 1B of clinical trials, advancing the development of this drug to treat solid tumours Made-in-Singapore cancer drug, ETC-159, has achieved a new developmental milestone in achieving “First Patient First Visit[1]” in Phase 1B. The first dose of ETC-159 has been administered to patients in this new phase of.

article thumbnail

Survey: Gen Z’ers Want to Eat More Plant-Based and Vegan Foods

XTalks

Gen Z is setting food trends in the post-pandemic world, The Food Institute reports, and their food choices include: Ordering in more, choosing frozen foods and eating more plant-based meals. They believe you don’t have to be vegan to want to eat more vegan foods, the Institute report noted, in a review of how these young consumers are influencing food trends.

Protein 116
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How to Know If your Toddler Has Tooth Decay and How to Reverse It?

Pharma Mirror

What is a toddler tooth decay? Do you have children in your house? Then you must face the problem of dental cavities and tooth decay and have to deal with these as well. Usually, the decay of the tooth is a breakdown or destruction of tooth enamel. We all know the fact that enamel is. The post How to Know If your Toddler Has Tooth Decay and How to Reverse It?

130
130
article thumbnail

MHRA OKs Celltrion's Phase I trial of COVID drug

Pharma Times

The trial will enrol patients with mild symptoms of SARS-CoV-2 infection to evaluate the safety, tolerability, efficacy, pharmacokinetics and immunogenicity of CT-P59

Trials 102
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Dunkin’ and Bark Bringing Joy to Children

XTalks

Starting next week, Dunkin’ and Bark are collaborating to create a new Dunkin’ inspired plush dog toy being sold in restaurants nationwide. Proceeds are going to the Dunkin’ Joy in Childhood Foundation. The Dunkin’ Joy in Childhood Foundation and Bark are creating dog toys in the shape of Munchkins donut holes and hot coffee cups. The toys will be available at the beginning of August and will be sold in participating restaurants while supplies last.

article thumbnail

Parexel: improving trial diversity can elevate outcomes

Outsourcing Pharma

A representative from the pharma services firm discusses how increasing diversity of clinical trial populations can improve research effectiveness.

Trials 98

More Trending

article thumbnail

Kodak Pharmaceuticals lands $765m US loan

Outsourcing Pharma

The imaging companyâs newly launched division, created to produce drug ingredients, received the loan from the US International Development Finance Corp.

article thumbnail

EU regulators approve Novartis' breast cancer combo

Pharma Times

Piqray in combination with fulvestrant is the first treatment for tumours with a PIK3CA mutation

article thumbnail

Moderna enters P3 trials for vaccine, with $483m BARDA push

BioPharma Reporter

US government supports Modernaâs clinical program for its COVID-19 vaccine with financial backing.

article thumbnail

A Complex Chromosomal Abberation Called Adrenoleukodystrophy

Delveinsight

The global Adrenoleukodystrophy market size for the forecast period 2020-30, which was estimated to be USD 922.43 million in the 7MM in 2017 is driven by key pharma players such as Bluebird Bio , Minoryx Therapeutics , MedDay Pharmaceuticals , Magenta Therapeutics , and others are proactively focusing on advancing ALD pipeline, increasing prevalence, and increased R&D in the domain.

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Stimulus Payments, Health Insurance, & Returning to Work During COVID-19

Triage Cancer

National Updates. Have you not gotten your economic impact payment yet? Or have you had children during 2020? You may need to file more information with the IRS! On June 3 rd , the IRS announced that its non-filer tool will only be available until October 15 th. The non-filer tool is a resource which allows low-income individuals and others not required to file income tax returns in 2018 or 2019, and have not received payments automatically, to register to ensure that they receive economic impac

52
article thumbnail

Vendor Qualification vs Requalification Audits: What’s the Difference?

Forte Research Systems®

When supporting vendor qualification and management programs, there are different audits to consider. This article defines the differences and how to identify vendors with potential risk for your program.

52
article thumbnail

What Every Healthcare Marketer Needs to Know About Inclusive Marketing

Intouch Solutions

Marketing that accurately reflects the population matters more than ever. Reaching out appropriately to untapped audiences offers brands enormous potential to make a difference. In this POV, senior RM strategist Chanel Hemphill discusses best practices for marketing to the Black community. The post What Every Healthcare Marketer Needs to Know About Inclusive Marketing appeared first on Intouch Solutions.

article thumbnail

Most recent FDA COVID-19 updates

Outsourcing Pharma

The US agency continues to put out informational resources, issue EUAs for tests and treatments, and monitor industry activity related to the virus.

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

GSK sees dip in second-quarter sales

Pharma Times

Sales decline in the second quarter reflects expected disruption from COVID-19

Sales 65
article thumbnail

Kite gets second CAR-T approval, 96% manufacturing success rate

BioPharma Reporter

Kite becomes the first company to have two approved CAR-T treatments, with its second targeting rare form of lymphoma.

article thumbnail

NICE backs Bavencio combo for kidney cancer

Pharma Times

The combination of an immunotherapy with a targeted antiangiogenic therapy offers patients a novel treatment option

54
article thumbnail

Free Patent Litigation Docket Reports Data

Drug Patent Watch

The USPTO Office of the Chief Economist has releases a comprehensive set of patent litigation data files for public use. The Patent Litigation Dataset has been updated as of December…. The post Free Patent Litigation Docket Reports Data appeared first on DrugPatentWatch - Make Better Decisions.

52
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19 neutralising Affimer therapy

Drug Discovery Today

Collaboration to develop stem cell therapies for COVID-19 and future pandemic diseases

article thumbnail

Granulation for the Nutraceutical Market: Improve Your Process Efficiencies and Product Quality

Syntegon Technology Pharma Blog

article thumbnail

Roche-UCB’s $120M collaboration; Omega snags $85M; ExeVir raises $27M; GSK culls pipeline meds after failures

Delveinsight

Roche bets USD 120 Million on UCB’s anti-tau Alzheimer’s antibody. The Swiss pharma, Roche, is handing over USD 120 million upfront for the right of UCB’s anti-tau antibody development. If everything goes according to plan, milestone payments and royalties could bring the deal’s total near to USD 2 billion. The drug, UCB0107, is designed to impede or decrease the buildup of tau proteins in the brain, which leads to nerve cell damage and death.

article thumbnail

Nirsevimab shows promise for long-term RSV protection

Pharma Times

The monoclonal antibody is the first potential passive immunisation for infants to demonstrate sustained protection across the entire RSV season with a single dose

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.